Volume | 450 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 11,20 | Bas Haut |
|||||
Minimum Bas | 11,20 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Bellevue Life Sciences Acquisition Corporation | BLACU | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
11,20 | 11,20 | 11,20 | 11,20 | 11,285 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
3 | 450 | US$ 11,20 | US$ 5 040 | - | 10,085 - 11,45 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
22:00:00 | 450 | US$ 11,20 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
68,99M | 6,43M | - | 0 | 404k | 0,06 | 170,86 |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Bellevue Life Sciences A...
Date | Heure | Source | Titre |
---|---|---|---|
21/2/2024 | 22:20 | Edgar (US Regulatory) | Form 8-K - Current report |
13/2/2024 | 15:00 | Edgar (US Regulatory) | Form 8-K - Current report |
08/2/2024 | 22:20 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
05/2/2024 | 19:48 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
16/11/2023 | 23:00 | PR Newswire (US) | OSR Holdings Co., Ltd. Enters Into Business Combination.. |
16/11/2023 | 22:37 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business.. |
16/11/2023 | 22:35 | Edgar (US Regulatory) | Form 8-K - Current report |
15/11/2023 | 12:04 | Edgar (US Regulatory) | Form 8-K - Current report |
07/11/2023 | 22:20 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
20/10/2023 | 22:20 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements |
10/10/2023 | 23:00 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements |
14/8/2023 | 22:45 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
Forum Action Bellevue Life Sciences A...
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Bellevue Life Sciences Acquisition Corporation
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 0,00 | 11,20 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
1 mois | 0,00 | 11,20 | 0,00 | 0,00 | 0 | 0,00 | 0,00% |
3 mois | 10,73 | 11,285 | 10,73 | 10,96 | 85 | 0,47 | 4,38% |
6 mois | 10,6636 | 11,285 | 10,085 | 10,63 | 913 | 0,5364 | 5,03% |
1 an | 10,4139 | 11,45 | 10,085 | 10,44 | 2 167 | 0,7861 | 7,55% |
3 ans | 10,17 | 11,45 | 10,085 | 10,21 | 15 446 | 1,03 | 10,13% |
5 ans | 10,17 | 11,45 | 10,085 | 10,21 | 15 446 | 1,03 | 10,13% |